Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-07-09Clinical Trial Update: Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial of nitrocamptothecin for recurrent or metastatic ovarian cancer and primary peritoneal cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating combination chemotherapy for newly diagnosed Stage III/IV ovarian cancer or primary peritoneal cancer has been te…
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors [Phase 2]
Phase 2 trial evaluating combination chemotherapy with amifostine to treat malignant germ cell tumors in children; the study status is compl…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Chemotherapy in Treating Patients With Solid Tumors [Phase 1, Phase 2]
The update notes completion of Phase 1 and Phase 2 trials of a chemotherapy regimen in patients with solid tumors. It includes multiple canc…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating a combination chemotherapy regimen in patients with germ cell tumors that have not responded…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-06-27Clinical Trial Update: Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve [NA]
This clinical trial update compares salpingectomy with tubal sterilisation in women at low risk for ovarian cancer and assesses the effect o…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating paclitaxel for recurrent or progressive advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer [Phase 2]
A Phase 2 clinical trial of Bryostatin 1 in patients with ovarian epithelial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of docetaxel and carboplatin in patients with ovarian cancer, fallopian tube cancer, or …
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for TLK286 in advanced ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer; the st…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors [Phase 2]
A Phase 2 trial update evaluating a combination chemotherapy regimen for children with non-testicular malignant germ cell tumors, including …
-
FDA approval · 2013-06-26FDA Approved: TOPOTECAN HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's original application for a generic topotecan hydrochloride product.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating topotecan in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors [Phase 1]
Phase 1 trial evaluating combination chemotherapy in previously untreated, newly diagnosed epithelial tumors, including endometrial cancer, …
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
The document reports results from a completed Phase 2 trial of gefitinib in patients with recurrent or persistent ovarian epithelial cancer …
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors [Phase 2]
A Phase 2 trial of ixabepilone in patients with advanced cisplatin-refractory germ cell tumors has completed, evaluating outcomes across cen…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating capecitabine for recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum [Phase 2]
Phase 2 trial of aminocamptothecin in recurrent or refractory ovarian epithelial cancer and primary peritoneal cancer completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
This Phase 2 trial evaluated the combination of cisplatin and irinotecan in patients with fallopian tube, ovarian, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy [Phase 2]
A Phase 2 trial of oxaliplatin for patients with recurrent or refractory ovarian epithelial cancer or primary peritoneal cancer that did not…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Gefitinib in Treating Patients With Cervical Cancer [Phase 2]
A Phase 2 clinical trial evaluating gefitinib in patients with cervical cancer and related gynecologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
This is a Phase 2 clinical trial update for irofulven in recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer. The …
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors [Phase 1, Phase 2]
This clinical trial update covers the pediatric use of temozolomide in combination with peripheral stem cell transplantation for newly diagn…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer [Phase 2]
This is a Phase 2 clinical trial update of vaccine therapy and biological therapy for advanced cancers across multiple indications, with the…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of carboxyamidotriazole for refractory or recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer has compl…